Cannabinoides
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (29)
2024
-
Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression
Cancers, Vol. 16, Núm. 4
-
Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle
Cancer Letters, Vol. 585
-
Mechanisms of mesothelial cell response to viral infections: HDAC1-3 inhibition blocks poly(I:C)-induced type I interferon response and modulates the mesenchymal/inflammatory phenotype
Frontiers in Cellular and Infection Microbiology, Vol. 14
-
Metal-based nanoparticles in cancer therapy: Exploring photodynamic therapy and its interplay with regulated cell death pathways
International Journal of Pharmaceutics, Vol. 649
-
Metastatic outgrowth via the two-way interplay of autophagy and metabolism
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 3
-
POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1
Molecular Oncology, Vol. 18, Núm. 3, pp. 620-640
-
The obesity-autophagy-cancer axis: Mechanistic insights and therapeutic perspectives
Seminars in Cancer Biology, Vol. 99, pp. 24-44
-
Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies
Cell Communication and Signaling, Vol. 22, Núm. 1
2023
-
Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery
European Journal of Pharmacology, Vol. 958
-
Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43
Nature Communications, Vol. 14, Núm. 1
-
Correction to: Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective (Cell & Bioscience, (2023), 13, 1, (44), 10.1186/s13578-023-00986-9)
Cell and Bioscience
-
Editorial: Autophagy modulation in cancer treatment utilizing nanomaterials and nanocarriers
Frontiers in Oncology
-
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk
Cells, Vol. 12, Núm. 15
-
Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers
Current Oncology, Vol. 30, Núm. 3, pp. 2569-2581
-
Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective
Cell and Bioscience, Vol. 13, Núm. 1
-
Pseudokinases, Tribbles Proteins and Cancer
Cancers
2022
-
Discovery of Mitophagy Inhibitors with Therapeutic Potential in Different Familial Amyotrophic Lateral Sclerosis Mutations
International Journal of Molecular Sciences, Vol. 23, Núm. 20
-
Sirtuins and Hypoxia in EMT Control
Pharmaceuticals, Vol. 15, Núm. 6
-
Transcriptomic Mapping of Non-Small Cell Lung Cancer K-RAS p.G12C Mutated Tumors: Identification of Surfaceome Targets and Immunologic Correlates
Frontiers in Immunology, Vol. 12
2021
-
Identification of bip as a cb1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain
Journal of Neuroscience, Vol. 41, Núm. 38, pp. 7924-7941